General MedicationsINJECTIONGeneric
BORTEZOMIB
BORTEZOMIB
Standard Dose
2.5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview BORTEZOMIB is listed in Drugs@FDA under application 208645 (NDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BORTEZOMIB Form and strength INJECTABLE; INJECTION - 2.5MG/ML Sponsor ACTAVIS LLC Submission history Latest submission status date: 2016-10-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview BORTEZOMIB is listed in Drugs@FDA under application 208645 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient BORTEZOMIB Form and strength INJECTABLE; INJECTION - 2.5MG/ML Sponsor ACTAVIS LLC Submission history Latest submission status date: 2016-10-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.